Stem cell research has a big problem, and we're here to solve it. Currently, the stem cell technologies market value stands at $14bn with a global input of $2.2bn in 2024 alone. So why are there only 30 approved stem cell derived therapies globally? Why, also, are none of these 30 derived from embryonic or induced pluripotent stem cell start points?

The answer is waste. Waste which comes from a lack of standardisation across stem cell research and manufacturing. Waste which results in 70% of stem cell research lacking reproducibility or a tangible output. Waste which means 99.8% of stem cell therapeutic clinical trials will fail. Current stem cell project management methodologies are poorly equipped to offset this waste. There are no gold standard processes for stem cell research and manufacturing in the academic and commercial sector. Similarly, current troubleshooting and optimisation processes are logistically demanding and reliant on long end to end development cycles. Failed processes therefore extend beyond acceptable parameters and yet the sector lacks the tools to implement change.

We are a team of stem cell biologists and AI experts who decided make this change. We present Protostem-AI, the world's first end to end project management tool tailored to stem cell research and manufacturing. Our application allows multiple users to design and monitor stem cell projects. Using agentic AI and federated learning models Protostem-AI can spot developing problems in real time, suggesting process additions and changes to guarantee successful outcomes. Protostem-AI can suggest equipment available to hand, monitor consumable stock levels and implement ordering when needed. Finally, the application can collate research outputs into bespoke formats, from in house reports to publications and patent applications. 

If you would like to learn more please visit our website or contact our CEO at Dominic@protostem-ai.com.



Protostem-AI

Org chart

Teams

Offices

Protostem-AI

Org chart

Teams

Offices

Related companies